Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study

NCT06486142 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT06486142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06486142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study
Lead sponsor
Region Skane
Phase
Phase 3
Overall status
Recruiting
Start date
September 21, 2022
Completion date
September 30, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer